<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2020.115027</article-id><article-id pub-id-type="publisher-id">IJCM-100229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological Pattern of Breast Diseases among Females in the South-Western Region, Saudi Arabia
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdulrahman</surname><given-names>Manaa Alamri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saeed</surname><given-names>Ali Alsareii</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hajr</surname><given-names>Al-Wadei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Awad</surname><given-names>Mohammed Al-Qahtani</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Salem</surname><given-names>Ali Alatef Sultan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sara</surname><given-names>Ali Alshamrani</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmed</surname><given-names>Hamzah Almakrami</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdullah</surname><given-names>Ahmed Daiel</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahlam</surname><given-names>Yahya Alyami</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ashwaq</surname><given-names>Mousa Hommadi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yagoub</surname><given-names>Mohammed Tahir Ali</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Surgery, College of Medicine, Najran University, Najran, KSA</addr-line></aff><aff id="aff3"><addr-line>College of Medicine, Najran University, Najran, KSA</addr-line></aff><aff id="aff2"><addr-line>Department of Community Medicine, Faculty of Medicine, Najran University, Najran, KSA</addr-line></aff><aff id="aff4"><addr-line>Department of General surgery, King Khalid Hospital, Najran, KSA</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>04</month><year>2020</year></pub-date><volume>11</volume><issue>05</issue><fpage>257</fpage><lpage>269</lpage><history><date date-type="received"><day>15,</day>	<month>April</month>	<year>2020</year></date><date date-type="rev-recd"><day>12,</day>	<month>May</month>	<year>2020</year>	</date><date date-type="accepted"><day>15,</day>	<month>May</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background
  : Breast diseases cover several conditions. The majority of breast diseases are noncancerous. Some of these lesions are clinically unremarkable, which needed minimal intervention. However, some symptoms may be of clinical value and attract the attention of both the patient and the attending physician, especially when they become persistent. The study aimed to assess the prevalence, pattern, types, and clinical profile of breast diseases among females in the South-western region, during the period from 2018-2020. 
  Methods: A retrospective record-based descriptive approach was used through reviewing medical records of all cases with breast disease attended King Khalid Hospital during the period from January 2018 to January 2020. Data extracted throng pre-structured questionnaire. 
  Results: The study included 211 cases whose ages ranged from 18 to 58 years old with a mean age of 28.9 &#177; 12.8 years. Breast mass was the most recorded complaint (95.1%) followed with breast pain (32%), skin changes. Benign findings based on the final pathology report were recorded for more than two thirds of the cases, with the most common finding were fibroadenoma. Excisional biopsy and modified radical mastectomy were the most reported surgical interventions. 
  Conclusions: In conclusion, the study revealed that the majority of the cases had benign breast disease (BBD), where fibroadenoma was the most frequent.
 
</p></abstract><kwd-group><kwd>Breast Disease</kwd><kwd> Females</kwd><kwd> Incidence</kwd><kwd> Pattern</kwd><kwd> Predictors</kwd><kwd> Epidemiolo-gylesions</kwd><kwd> Biopsy</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Background</title><p>Breast diseases make up several conditions. The majority of breast diseases are noncancerous [<xref ref-type="bibr" rid="scirp.100229-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref2">2</xref>]. Breast lesions are mainly recorded among females. The most recorded cause of breast problems in females is a benign breast disease, which is 10 times more common than breast cancer in most countries [<xref ref-type="bibr" rid="scirp.100229-ref3">3</xref>]. Some of these lesions are clinically unremarkable, which needed minimal intervention. However, some symptoms may be of clinical value and attract the attention of both the patient and the attending physician, especially when they become persistent. The main item behind that concern is the possibility of the occurrence of breast cancer, which is usually asymptomatic in the early stages during which it is curable [<xref ref-type="bibr" rid="scirp.100229-ref4">4</xref>]. Benign breast diseases are mainly prevalent during the reproductive age as the incidence is common mainly in the second decade with realization on its peak at fourth and fifth life year’s decade [<xref ref-type="bibr" rid="scirp.100229-ref5">5</xref>]. Benign breast diseases include many and variable histological patterns categorized into non-proliferative breast lesions, proliferative breast lesions without atypia, and proliferative breast lesions with atypia [<xref ref-type="bibr" rid="scirp.100229-ref6">6</xref>] besides fibroadenoma, fibrocystic change, and breast abscess are the most recorded benign lesions in the literature [<xref ref-type="bibr" rid="scirp.100229-ref7">7</xref>]. Certain types of benign breast lesions were recorded as a significant risk factor for developing breast cancer [<xref ref-type="bibr" rid="scirp.100229-ref8">8</xref>]. Women with benign proliferative or atypical breast lesions consume a two-fold risk of developing breast cancer in western populations [<xref ref-type="bibr" rid="scirp.100229-ref9">9</xref>].</p><p>The literatures covered the histopathological pattern of breast diseases with less attention for the clinical perspectives [<xref ref-type="bibr" rid="scirp.100229-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref12">12</xref>]. Surgical evaluation of the symptomatic patients by triple assessment, namely, clinical examination of the breast, mammography, and breast biopsy for definitive histological diagnosis is required in many patients [<xref ref-type="bibr" rid="scirp.100229-ref13">13</xref>].</p><p>The current study aimed to assess the prevalence, pattern, types, and clinical profile of breast diseases among females in the South-western region, during the period from 2018-2020.</p></sec><sec id="s2"><title>2. Methodology</title><p>Retrospective record-based descriptive approach was used through reviewing medical records of all cases that were admitted and have breast disease (benign or malignant breast masses) in King Khalid Hospital during the period from January 2018 to January 2020. Records with missing data were included. Data extracted through pre-structured questionnaire including patient's bio-clinical data, initial clinical presentation of the breast disease, radiological assessment findings. Also, the final pathological findings were extracted besides the nature of the assigned pathology. Data also included the type of surgery and post operative outcome.</p></sec><sec id="s3"><title>3. Statistical Analysis</title><p>After data were extracted, it was revised, coded, and fed to statistical software IBM SPSS version 22 (SPSS, Inc. Chicago, IL). All statistical analysis was done using the two-tailed test. A P-value of less than 0.05 is considered being statistically significant. Descriptive analysis based on frequency and percent distribution was done for all variables, including demographic data, breast disease nature, and types, clinical presentation, and surgery outcome.</p></sec><sec id="s4"><title>4. Results</title><p>The study included 211 cases whose ages ranged from 18 to 58 years old with a mean age of 28.9 &#177; 12.8 years. Exact of 59 (72%) of the females were married, and all of the sampled females started menstruation at the age of 18 years with regular menstrual cycle. Ten (67%) of the females are still menstruating. Only one (10%) of the study females had the first pregnancy before the age of 20 years and 10% above the age of 30 years. As for gravidity, 3 (10.3%) of the females had no pregnancy, while 31% had four pregnancies or more. Considering co-morbidity, diabetes mellitus was recorded among 5 (9.6%) of the females and 8 females (15.4%) had hypothyroidism (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p><xref ref-type="table" rid="table2">Table 2</xref> demonstrates the determinants of having breast disease. Oral contraceptive pills were received by 8 (40%) of the study females, and 30.8% of them had hormonal therapy. A family history of breast disease, including breast cancer, was recorded for 4 females (23.5%). Only 8 (44.4%) of the females know about breast screening for early detection of breast lesions, while 23 females (85.2%) do breast examination regularly. Only one case recorded that she performs regular breast screening after the age of 40 years.</p><p>Concerning clinical data of recorded breast diseases (<xref ref-type="table" rid="table3">Table 3</xref>), breast mass was the most recorded complaint as recorded for 196 females (95.1%) followed with breast pain which was among 66 females (32%), skin changes (11; 5.3%), and nipple discharge (8; 3.9%). The symptoms = appeared for less than one month among 23.5% of the cases while lasted for more than 6 months among 52 females (39.4%). As for the affected side, the right side was dominant among 84 females (41.2%) of the cases while it was bilateral among 19 (9.3%). The breast mass measured less than 2 cm among 60 (37.5%) of the cases while it was more than 5 cm among 21 females (13.1%) of them. Margins of the breast mass were irregular among 46.2% of the cases, and the mass was soft among 59 of the patients (54.1%). Skin changes were recorded for 28 (22.2%) of the cases, and 53 cases (34.9%) had positive Axillary lymph nodes on physical examination.</p><p>Considering radiological and biopsy findings among the cases, <xref ref-type="table" rid="table4">Table 4</xref> illustrates that the most recorded US finding was Fibrocystic disease (64; 49.6%) followed with cancer related features (29; 22.5%), breast abscess (8.5%), and fibroadenoma</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Personal and obstetric data for female patients with breast diseases in Najran, Southern Saudi Arabia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Personal &amp; obstetric data</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="5"  >Age in years</td><td align="center" valign="middle" >&lt;20 years</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >8.1%</td></tr><tr><td align="center" valign="middle" >20 - 30</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >19.9%</td></tr><tr><td align="center" valign="middle" >30 - 40</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >30.8%</td></tr><tr><td align="center" valign="middle" >40 - 50</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >35.5%</td></tr><tr><td align="center" valign="middle" >50+</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >5.7%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Marital status (n = 82)</td><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >23.2%</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >72.0%</td></tr><tr><td align="center" valign="middle" >Divorced/widow</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.9%</td></tr><tr><td align="center" valign="middle" >Age of menarche</td><td align="center" valign="middle" >&lt;18 years</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >100.0%</td></tr><tr><td align="center" valign="middle" >Regular menstrual cycle</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >100.0%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Age of menopause (n = 15)</td><td align="center" valign="middle" >Not at menopause</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >66.7%</td></tr><tr><td align="center" valign="middle" >40 - 49 years</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >33.3%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age of pregnancy (n = 10)</td><td align="center" valign="middle" >&lt;20 years</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10.0%</td></tr><tr><td align="center" valign="middle" >20 - 30</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >80.0%</td></tr><tr><td align="center" valign="middle" >30+</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10.0%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >No. of pregnancies (n = 29)</td><td align="center" valign="middle" >Nulligravida</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >10.3%</td></tr><tr><td align="center" valign="middle" >1 - 3</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >58.6%</td></tr><tr><td align="center" valign="middle" >4+</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >31.0%</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Co-morbidity</td><td align="center" valign="middle" >None</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >19.2%</td></tr><tr><td align="center" valign="middle" >DM</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >9.6%</td></tr><tr><td align="center" valign="middle" >HTN</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13.5%</td></tr><tr><td align="center" valign="middle" >Hypothyroidism</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >15.4%</td></tr><tr><td align="center" valign="middle" >Asthma</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.8%</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >15.4%</td></tr><tr><td align="center" valign="middle" >Diabetic and HTN</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >21.2%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Factors related to have breast disease among female patients in Najran, Southern Saudi Arabia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Factors related to breast diseases</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Oral contraceptive pills</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >60.0%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >40.0%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Hormonal therapy</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >69.2%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >30.8%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Family history of breast disease</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >76.8%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >23.2%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Family history of other cancers</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >76.5%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >23.5%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Know about breast screening</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >55.6%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >44.4%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Regular Breast Examination</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >14.8%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >85.2%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Who did the examination</td><td align="center" valign="middle" >By herself</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >52.2%</td></tr><tr><td align="center" valign="middle" >By physician</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >47.8%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Regular breast screening after age 40</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >75.0%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >25.0%</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Clinical data of breast diseases among female patients in Najran, Southern Saudi Arabia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Clinical data</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="8"  >Clinical signs &amp; symptoms</td><td align="center" valign="middle" >Mass</td><td align="center" valign="middle" >196</td><td align="center" valign="middle" >95.1%</td></tr><tr><td align="center" valign="middle" >Pain</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >32.0%</td></tr><tr><td align="center" valign="middle" >Skin changes</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.3%</td></tr><tr><td align="center" valign="middle" >Nipple changes</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >3.9%</td></tr><tr><td align="center" valign="middle" >Swelling</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >Discharge</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.0%</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.0%</td></tr><tr><td align="center" valign="middle" >Axillary mass</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5%</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Duration of symptoms</td><td align="center" valign="middle" >&lt;1 month</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >23.5%</td></tr><tr><td align="center" valign="middle" >1 - 2 ms</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >22.0%</td></tr><tr><td align="center" valign="middle" >3 - 6 ms</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >15.2%</td></tr><tr><td align="center" valign="middle" >&gt;6 months</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >39.4%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Side of lesion</td><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >41.2%</td></tr><tr><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >49.5%</td></tr><tr><td align="center" valign="middle" >Bilateral</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >9.3%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Mass size</td><td align="center" valign="middle" >&lt;2 cm</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >37.5%</td></tr><tr><td align="center" valign="middle" >2 - 5 cm</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >49.4%</td></tr><tr><td align="center" valign="middle" >&gt;5 cm</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >13.1%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Margins of mass</td><td align="center" valign="middle" >Irregular</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >46.2%</td></tr><tr><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >53.8%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Mass consistency</td><td align="center" valign="middle" >Soft</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >54.1%</td></tr><tr><td align="center" valign="middle" >Hard</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >45.9%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Skin changes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >77.8%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >22.2%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Nipple discharge</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >90.5%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >9.5%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Nipple retraction</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >84.8%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >15.2%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Nipple destruction</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >98.9%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Positive axillary lymph nodes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >65.1%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >34.9%</td></tr></tbody></table></table-wrap><table-wrap-group id="4"><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Radiological and biopsy findingsamongfemale patients with breast disease in Najran, Southern Saudi Arabia</title></caption><table-wrap id="4_1"><table><tbody><thead><tr><th align="center" valign="middle" >Radiological and biopsy findings</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="11"  >US findings</td><td align="center" valign="middle" >Fibrocystic disease</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >49.6%</td></tr><tr><td align="center" valign="middle" >Cancer</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >22.5%</td></tr><tr><td align="center" valign="middle" >Breast abscess</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >8.5%</td></tr><tr><td align="center" valign="middle" >Fibroadenoma</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >7.8%</td></tr><tr><td align="center" valign="middle" >Phyllodes</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.9%</td></tr><tr><td align="center" valign="middle" >Unremarkable</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >Galactocele</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Lactating adenoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Mastitis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Mature adipose tissue with fibrous tissue</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Antibioma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle"  rowspan="8"  >Mammogram findings</td><td align="center" valign="middle" >Speculated mass</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >35.9%</td></tr><tr><td align="center" valign="middle" >Microcalcification</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >25.6%</td></tr><tr><td align="center" valign="middle" >Microcalcification, Speculated mass</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >23.0%</td></tr><tr><td align="center" valign="middle" >Texture distortion</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5.1%</td></tr><tr><td align="center" valign="middle" >Fatty glandular breast parenchyma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6%</td></tr><tr><td align="center" valign="middle" >Mixed fibro-fatty glandular breast prynchema</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6%</td></tr><tr><td align="center" valign="middle" >Multi cystic</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6%</td></tr><tr><td align="center" valign="middle" >Oil cyst</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >MRI impression</td><td align="center" valign="middle" >Benign</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >41.2%</td></tr><tr><td align="center" valign="middle" >Malignant</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >58.8%</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Type of biopsy</td><td align="center" valign="middle" >Excisional</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >19.6%</td></tr><tr><td align="center" valign="middle" >True cut</td><td align="center" valign="middle" >117</td><td align="center" valign="middle" >65.4%</td></tr><tr><td align="center" valign="middle" >Fine needle aspiration cytology (FANC)</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >12.8%</td></tr><tr><td align="center" valign="middle" >Incisional</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.7%</td></tr><tr><td align="center" valign="middle" >Lumpectomy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >.6%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Final pathology report</td><td align="center" valign="middle" >Benign</td><td align="center" valign="middle" >124</td><td align="center" valign="middle" >63.9%</td></tr><tr><td align="center" valign="middle" >Malignant</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >36.1%</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Nature of lesion</td><td align="center" valign="middle" >Fibroadenoma</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >42.9%</td></tr><tr><td align="center" valign="middle" >Fibrocystic</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >18.8%</td></tr><tr><td align="center" valign="middle" >Invasive ductal carcinoma (IDC)</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >18.8%</td></tr><tr><td align="center" valign="middle" >Breast abscess</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >5.4%</td></tr><tr><td align="center" valign="middle" >Atypical ductal hyperplasia</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.3%</td></tr><tr><td align="center" valign="middle" >Mucinous carcinoma</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.3%</td></tr><tr><td align="center" valign="middle" >Antibioma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr></tbody></table></table-wrap><table-wrap id="4_2"><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="16"  ></th><th align="center" valign="middle" >Acute and chronic breast inflammation</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >0.6%</th></tr></thead><tr><td align="center" valign="middle" >Ductal ectasia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Ductal hyperplasia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Epidermoid cyst</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Fibroepithelial lesion</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Gynecomastia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Invasive mammillary carcinoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Invasive papillary Ca</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Lactating adenoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Myofibroblastic tumor</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Periductal &amp; perilobular chronic inflammatory process</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Phylloid with free margin less than 1 mm</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Right axillary lipoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Sebaceous cyst</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Spidle cell tumor</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle" >Suggestive of tubular adenoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Ductal carcinoma in situ</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >56.3%</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >43.8%</td></tr></tbody></table></table-wrap></table-wrap-group><p>(10; 7.8%). Mammogram findings were also recorded with the most recorded one was speculated mass (14; 35.9%) followed with micro calcification (10; 25.6%), micro calcification with speculated mass (9; 23%), and texture distortion (2; 5.1%). MRI showed benign features among 21 cases (41.2%) of the cases. As for biopsy, 117 females (65.4%) of the cases undergone true cut biopsy followed with excisional biopsy (19.6%), and fine needle aspiration biopsy (12.8%). Benign findings based on final pathology report were diagnosed for 124 (63.9%) of the cases with the most common finding was fibroadenoma (66; 42.9%) followed with the fibrocystic disease (29; 18.8%), IDC (29; 18.8%) and breast abscess (9; 5.4%). Ductal carcinoma in situ was recorded for 43.8% of the cases.</p><p><xref ref-type="table" rid="table5">Table 5</xref> shows that Estrogens/Progestin Receptors were positive among 28 females (73.7%) of the cases and Human epidermal growth factor receptor 2 (HER2) was positive for 11 cases (30.6%) of the cases while Antigen Ki-67 was more than 12% among 10 cases (76.9%).</p><p>Regarding surgery and clinical outcome (<xref ref-type="table" rid="table6">Table 6</xref>), excisional Biopsy was the most surgical procedure (53; 41.1%) followed with modified radical mastectomy (28; 21.7%), lumpectomy (23; 11.6%) while 17.8% of the cases were not operated.</p></sec><sec id="s5"><title>5. Discussion</title><p>Researchers reported wide variability in the frequency and distribution of breast</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Laboratory findings among female patients with breast disease in Najran, Southern Saudi Arabia</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Laboratory findings</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Estrogens/progestin receptors</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >26.3%</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >73.7%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Human epidermal growth factor receptor 2 (HER2)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >69.4%</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >30.6%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Antigen Ki-67</td><td align="center" valign="middle" >Less than 12%</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >23.1%</td></tr><tr><td align="center" valign="middle" >More than 12%</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >76.9%</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Surgery data forfemale patients with breast disease in Najran, Southern Saudi Arabia</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Surgery data</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Type of surgery</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Excisional biopsy</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >41.1%</td></tr><tr><td align="center" valign="middle" >Modified radical mastectomy</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >21.7%</td></tr><tr><td align="center" valign="middle" >Not operated</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >17.8%</td></tr><tr><td align="center" valign="middle" >Lumpectomy</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >11.6%</td></tr><tr><td align="center" valign="middle" >Incision and drainage</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.1%</td></tr><tr><td align="center" valign="middle" >Drainage</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >LAMA</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Not mentioned</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Simple mastectomy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Drainage</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8%</td></tr><tr><td align="center" valign="middle" >Surgery complications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >83.7%</td></tr><tr><td align="center" valign="middle" >Seroma</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >8.7%</td></tr><tr><td align="center" valign="middle" >Wound infection</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4.8%</td></tr><tr><td align="center" valign="middle" >Lymphedema</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >Echymosis around the wound</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0%</td></tr></tbody></table></table-wrap><p>ailments across the world [<xref ref-type="bibr" rid="scirp.100229-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref16">16</xref>]. Breast diseases more recorded among women than men, the prevalence rate in males ranging from 0% to 5.8% in most series, and the majority of male breast lesions are benign with gynaecomastia [<xref ref-type="bibr" rid="scirp.100229-ref17">17</xref>]. As for females, the pattern of pathology had high variability based on age and geographical location. Benign lesions are prevalent at all ages, constituting 48.9% to 57% with the main age of occurrence below the 30 years [<xref ref-type="bibr" rid="scirp.100229-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref19">19</xref>].</p><p>Benign breast lesions are more presented than cancer [<xref ref-type="bibr" rid="scirp.100229-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref22">22</xref>]. Benign breast diseases, however, formed a heterogeneous group of disorders, including developmental abnormalities, epithelial and stromal proliferation, inflammatory lesions, and neoplasms [<xref ref-type="bibr" rid="scirp.100229-ref23">23</xref>]. Breast cancer incidence increased from 12.7 million in 2008 to 14.1 million in 2012, and this trend is predicted to increase in the future [<xref ref-type="bibr" rid="scirp.100229-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100229-ref25">25</xref>]. It was estimated that worldwide over 508,000 women died in 2011 due to breast cancer [<xref ref-type="bibr" rid="scirp.100229-ref26">26</xref>]. Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden, and Japan to around 60% in middle-income countries and below 40% in low-income countries [<xref ref-type="bibr" rid="scirp.100229-ref27">27</xref>].</p><p>The current study aimed to assess the pattern of different breast diseases recorded for females in the south-western region, Saudi Arabia, during the period from January 2018 to January 2020. Also, the study aimed to assess the type of diagnostic and management methods with the clinical outcome. The study revealed that the majority of cases aged below 30 years and were married and still menstruating. Many risk factors for having breast diseases were recorded, including receiving oral contraceptive pills, hormonal therapy, positive family history, and irregular breast examination, especially at the age above 40 years. Breast mass was the most frequent complaint with breast pain with its size ranging from 2 - 5 cm in most cases and irregular margins in nearly half of the cases associated with Axillary lymph nodes in about 1 out of each 3 cases. Final pathology after a biopsy revealed that lesions were benign among two-thirds of the cases especially fibroadenoma, which is the most benign breast lesion. Regarding surgical intervention, modified radical mastectomy was needed for 1 out of each 5 cases, while only 11% of the cases undergone lumpectomy as the lesions were benign. Most of the cases had no post-operative complications less than 10% had seroma.</p><p>Generally, these findings were consistent with most of the literature. A study was conducted to assess benign breast lesions (BBD) in an African population [<xref ref-type="bibr" rid="scirp.100229-ref28">28</xref>] and recorded an increasing incidence of these benign lesions. The overall mean age for BBD was 27.5 years, SD &#177; 11.3, with an age range of 9 - 84 years and a peak age occurrence in the third decade. The single most common lesion was fibroadenoma accounting for 43.1% of cases, followed by fibrocystic change (23.8%). A second study was conducted by Ayoade BA et al. 2012 [<xref ref-type="bibr" rid="scirp.100229-ref29">29</xref>] to Clinical Features and Pattern of Presentation of Breast Diseases in Surgical Outpatient Clinic of a Suburban Tertiary Hospital in South-West, Nigeria. The researchers reported that the commonest symptoms were breast lump in 91.7% patients, and breast pain in 23.1% patients. Forty four patients (36.3%) had a malignant disease, seventy patients (57.8%) had benign breast diseases, and seven were normal. Fifty nine of the 70 benign diseases were fibroadenoma. In India, Hatim K et al. 2017 [<xref ref-type="bibr" rid="scirp.100229-ref30">30</xref>] conducted a research to assess Patterns and prevalence of benign breast disease in Western India. The reported that the commonest benign breast lesion was fibroadenoma (77.62%), followed by fibrocystic disease (4.3%) and gynaecomastia (4.3%).</p><p>Locally, Samir S et al. 1995 conducted a study to the spectrum of breast diseases in Saudi females [<xref ref-type="bibr" rid="scirp.100229-ref31">31</xref>]. The researchers reported that fibroadenoma was the most common lesion encountered 30.7%, followed by fibrocystic condition (21.1%), carcinoma (14.9%), acute mastitis (7.2%), duct ectasia (4.9%), lactational adenoma (4.8%), intraductal papilloma (2.6%), galactocele (2.4%) and several less frequent lesions. A second study was conducted to assess histopathological patterns of breast lesions in Northern Saudi Arabia, 2017 [<xref ref-type="bibr" rid="scirp.100229-ref32">32</xref>]. The study revealed that 23.2% of the lesions were ductal carcinoma, 4.4% were lobular carcinoma, 1.9% were mixed tumours, while 64.6% were fibroadenoma.</p><p>When local breast disease distribution patterns are known, skills related to diagnosis and management can be made with a sound degree of certainty. In addition, resource allocation and planning can be better allied. This is true mainly in low income countries where a large population of individuals may not afford diagnostic and management costs.</p></sec><sec id="s6"><title>6. Conclusion and Recommendations</title><p>In conclusion, benign breast diseases (BBD) were the most recorded among Najran females, especially fibroadenoma, with low post surgical complications. The better reporting system should be initiated, and well training for the physicians is mandatory to improve the quality of available data, and research based on these data and achieve better and more realistic conclusions for planning and resource allocation.</p></sec><sec id="s7"><title>Ethical Considerations</title><p>The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics and Research Committee of the College of Medicine of Najran University.</p></sec><sec id="s8"><title>Limitations of the Study</title><p>Irrespective of the variety of collected clinical data in the current study, but there were two main limitations. The first is the sample size, which was due to reviewing only 2 years’ cases, but this was due to a poor recording system, which somewhat primitive. The second was the high missing rate in the data for the cases, which also related to the primitive recording system and lack of physician’s experience regarding these cases management guidelines.</p></sec><sec id="s9"><title>Authors’ Contributions</title><p>Conceptualization, Abdulrahman Manaa sultan Alamri; methodology, Abdulrahman Manaa sultan Alamri, Saeed Ali Alsareii; data curation, Hajr Hassan Al-Wadei, Awad Mohammed Al-Qahtani, Salem Ali Alatef Sultan, Sara Ali Alshamrani, Ahmed Hamzah Almakrami, Abdullah Ahmed Daiel; writing original draft preparation, Ahlam Yahya Alyami, Ashwaq Mousa Hommadi, Yagoub Mohammed Tahir Ali; funding acquisition, All participants. All authors have read and agreed to the published version of the manuscript.</p></sec><sec id="s10"><title>Funding</title><p>This research was funded by all authors. No funding agency.</p></sec><sec id="s11"><title>Acknowledgements</title><p>All participants and included females were acknowledged.</p></sec><sec id="s12"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s13"><title>Cite this paper</title><p>Alamri, A.M., Alsareii, S.A., Al-Wadei, H.H., Al-Qahtani, A.M., Sultan, S.A.A., Alshamrani, S.A., Almakrami, A.H., Daiel, A.A., Alyami, A.Y., Hommadi, A.M. and Ali, Y.M.T. (2020) Epidemiological Pattern of Breast Diseases among Females in the South-Western Region, Saudi Arabia. International Journal of Clinical Medicine, 11, 257-269. https://doi.org/10.4236/ijcm.2020.115027</p></sec></body><back><ref-list><title>References</title><ref id="scirp.100229-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cosgrove, D.O., Kedar, R.P., Bamber, J.C., Al-Murrani, B.A., Davey, J.B., Fisher, C., McKinna, J.A., Svensson, W.E., Tohno, E. and Vagios, E. (1993) Breast Diseases: Color Doppler US in Differential Diagnosis. Radiology, 189, 99-104. https://doi.org/10.1148/radiology.189.1.8372225</mixed-citation></ref><ref id="scirp.100229-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Salzman, B., Fleegle, S. and Tully, A.S. (2012) Common Breast Problems. American Family Physician, 86, 343-349.</mixed-citation></ref><ref id="scirp.100229-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hatim, K.S., Laxmikant, N.S. and Mulla, T. (2017) Patterns and Prevalence of Benign Breast Disease in Western India. International Journal of Research in Medical Sciences, 5, 684-688.https://doi.org/10.18203/2320-6012.ijrms20170174</mixed-citation></ref><ref id="scirp.100229-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Aslam, H. M., Saleem, S., Shaikh, H. A., Shahid, N., Mughal, A. and Umah, R. (2013) Clinico-Pathological Profile of Patients with Breast Diseases. Diagnostic Pathology, 8, 77.https://doi.org/10.1186/1746-1596-8-77</mixed-citation></ref><ref id="scirp.100229-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">American Cancer Society. Atlanta: American Cancer Society. Breast Cancer Facts and Figures. https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html</mixed-citation></ref><ref id="scirp.100229-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Okoth, C., Galukande, M., Jombwe, J. and Wamala, D. (2013) Benign Proliferative Breast Diseases among Femalepatients at a Sub Saharan Africa Tertiary Hospital: A Cross Sectional Study. BMC Surgery, 13, 1-9. https://doi.org/10.1186/1471-2482-13-9</mixed-citation></ref><ref id="scirp.100229-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Chalya, P.L., Manyama, M., Rambau, P.F., Kapesa, A., Ngallaba, S.E., Masalu, N. and Mabula, J.B. (2016) Clinicopathological Pattern of Benign Breast Diseases among Female Patients at a Tertiary Health Institution in Tanzania. Tanzania Journal of Health Research, 18, 1.</mixed-citation></ref><ref id="scirp.100229-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Clavel-Chapelon, F. and Gerber, M. (2002) Reproductive Factors and Breast Cancer Risk. Do They Differ According to Age at Diagnosis. Breast Cancer Research and Treatment, 72, 107-115.https://doi.org/10.1023/A:1014891216621</mixed-citation></ref><ref id="scirp.100229-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Coriaty Nelson, Z., Ray, R.M., Gao, D.L. and Thomas, D.B. (2002) Risk Factors for Fibroadenoma in a Cohort of Female Textile Workers in Shanghai, China. American Journal of Epidemiology, 156, 599-605. https://doi.org/10.1093/aje/kwf094</mixed-citation></ref><ref id="scirp.100229-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gukas, I.D., Jennings, B.A., Mandong, B.M., Igun, G.O., Girling, A.C., Manasseh, A.N., et al. (2005) Clinicopathological Features and Molecular Markers of Breast Cancer in Jos. West African Journal of Medicine, 24, 209-213. https://doi.org/10.4314/wajm.v24i3.28220</mixed-citation></ref><ref id="scirp.100229-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anyanwu</surname><given-names> S.N. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Fibro-Adenoma of the Breast in Nigerian Igbos</article-title><source> South African Medical Journal</source><volume> 90</volume>,<fpage> 1223</fpage>-<lpage>1226</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.100229-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ntekim, A., Nufu, F.T. and Campbell, O.B. (2009) Breast Cancer in Young Women in Ibadan, Nigeria. Afr Health Sci., 9, 242-246.</mixed-citation></ref><ref id="scirp.100229-ref13"><label>13</label><mixed-citation publication-type="book" xlink:type="simple">Saunders, C.M. and Baum, C. (2000) The Breast in Bailey and Love’s Short Practice of Surgery. In: Russell, R.C., Williams, N.S. and Bulstrode, C.J., Eds., Bailey and Love’s Short Practice of Surgery, 23rd Edition, Arnold, London, 750-752.</mixed-citation></ref><ref id="scirp.100229-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chiedozi, L.C., El-Hag, I.A. and Kollur, S.M. (2003) Breast Diseases in the Northern Region of Saudi Arabia. Saudi Medical Journal, 6, 623-627.</mixed-citation></ref><ref id="scirp.100229-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jamal</surname><given-names> A.A. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>Pattern of Breast Diseases in a Teaching Hospital in Jeddah, Saudi Arabia</article-title><source> Saudi Medical Journal</source><volume> 2</volume>,<fpage> 110</fpage>-<lpage>113</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.100229-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Adesunkanmi, A.R. and Agbakwuru, E.A. (2001) Benign Breast Diseases at Wesley Guild Hospital, Ilesha Nigeria. West African Journal of Medicine, 2, 146-151.</mixed-citation></ref><ref id="scirp.100229-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Chaudhuri, M., Sens, S. and Sengupta, J. (1995) Breast Lumps: A Study of 10 Years. Journal of the Indian Medical Association, 12, 455-457.</mixed-citation></ref><ref id="scirp.100229-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Adeniji, K.A., Adelusola, K.A. and Odesanmi, W.O. (1997) Benign Disease of the Breast in Ile-Ife: A 10 Year Experience and Literature Review. Central African Journal of Medicine, 5, 140-143.</mixed-citation></ref><ref id="scirp.100229-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mansoor</surname><given-names> I. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>Profile of female breast lesions in Saudi Arabia</article-title><source> Journal of Pakistan Medical Association</source><volume> 7</volume>,<fpage> 243</fpage>-<lpage>247</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.100229-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Yusufu, L.M., Odigie, V.I. and Mohammed, A. (2003) Breast Masses in Zaria, Nigeria. Annals of African Medicine, 2, 13-16.</mixed-citation></ref><ref id="scirp.100229-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ochicha, O., Edino, S.T., Mohammed, A.Z. and Amin, S.N. (2002) Benign Breast Lesions in Kano. Nigerian Journal of Surgical Research, 4, 1-5. https://doi.org/10.4314/njsr.v4i1.12162</mixed-citation></ref><ref id="scirp.100229-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Anyikam, A., Nzegwu, M.A., Ozumba, B.C., Okoye, I. and Olusina, D.B. (2008) Benign Breast Lesions in Eastern Nigeria. Saudi Medical Journal, 29, 241-244.</mixed-citation></ref><ref id="scirp.100229-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tavassoli, F.A. and Devilee, P. (2003) World Health Organization Histological Classification of Tumours of the Breast in Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC, France.</mixed-citation></ref><ref id="scirp.100229-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">International Agency for Research on Cancer (2008) Cancer Incidence and Mortality World Wide. International Agency for Research on Cancer. IARC Cancer, Lyon. https://www.iarc.fr/wp-content/uploads/2018/07/pr223_E.pdf</mixed-citation></ref><ref id="scirp.100229-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D. (2013) Cancer Incidence and Mortality Worldwide. International Agency for Research on Cancer, Lyon, France, 120-163.</mixed-citation></ref><ref id="scirp.100229-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2013) Global Health Estimates. World Health Organization, Geneva.</mixed-citation></ref><ref id="scirp.100229-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Sun, J., Chen, X., Wang, Z., Guo, M., Shi, H., Wang, X., Cheng, L. and Zhou, M. (2015) A Potential Prognostic Long Non-Coding RNA Signature to Predict Metastasis-Free Survival of Breast Cancer Patients. Scientific Reports, 9 November 2015, 5, 16553.https://doi.org/10.1038/srep16553</mixed-citation></ref><ref id="scirp.100229-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Olu-Eddo, A.N. and Ugiagbe, E.E. (2011) Benign Breast Lesions in an African Population: A 25-Year Histopathological Review of 1864 Cases. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 52, 211. https://doi.org/10.4103/0300-1652.93790</mixed-citation></ref><ref id="scirp.100229-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ayoade, B.A., Tade, A.O. and Salami, B.A. (2012) Clinical Features and Pattern of Presentation of Breast Diseases in Surgical Outpatient Clinic of a Suburban Tertiary Hospital in South-West Nigeria. Nigerian Journal of Surgery, 18, 1.</mixed-citation></ref><ref id="scirp.100229-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Hatim, K.S., Laxmikant, N.S. and Mulla, T. (2017) Patterns and Prevalence of Benign Breast Disease in Western India. International Journal of Research in Medical Sciences, 5, 684-688.https://doi.org/10.18203/2320-6012.ijrms20170174</mixed-citation></ref><ref id="scirp.100229-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Amr, S.S., Sa’di, A.R., Ilahi, F. and Sheikh, S.S. (1995) The Spectrum of Breast Diseases in Saudi Arab Females: A 26 Year Pathological Survey at Dhahran Health Center. Annals of Saudi Medicine, 15, 125-132. https://doi.org/10.5144/0256-4947.1995.125</mixed-citation></ref><ref id="scirp.100229-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Ahmed, H.G., Al-Shammeri, K.J., Alrashidi, A.G., Alrashedi, S.A., Alenazi, F.S., Seada, L.S. and Ashankyty, I.M. (2017) Histopathologic Patterns of Breast Lesions in Northern Saudi Arabia. International Journal of Medical Research &amp; Health Sciences, 6, 54-64.</mixed-citation></ref></ref-list></back></article>